FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384156863> ?p ?o ?g. }

• W4384156863 endingPage "850" @default.
• W4384156863 startingPage "848" @default.
• W4384156863 abstract "In June, 2023, a Working Group of 25 scientists from 12 countries met at the International Agency for Research on Cancer (IARC) in Lyon, France, to finalise their evaluation of the carcinogenicity of aspartame, methyleugenol, and isoeugenol. Aspartame was classified as “possibly carcinogenic to humans” (Group 2B) based on “limited” evidence for cancer in humans. There was also “limited” evidence for cancer in experimental animals and “limited” mechanistic evidence. Methyleugenol was classified as “probably carcinogenic to humans” (Group 2A) based on “sufficient” evidence for cancer in experimental animals and “strong” mechanistic evidence, including studies in humanised mice and supported by mechanistic studies in exposed humans. Isoeugenol was classified as “possibly carcinogenic to humans” (Group 2B) based on “sufficient” evidence for cancer in experimental animals. For both methyleugenol and isoeugenol, the evidence regarding cancer in humans was “inadequate”, as no epidemiological studies were available. These assessments will be published in Volume 134 of the IARC Monographs. 1 International Agency for Research on Cancer. Volume 134: Aspartame, methyleugenol, and isoeugenol. Lyon, France; June 6–13, 2023. IARC Monogr Identif Carcinog Hazards Hum (in press). Google Scholar Immediately following IARC's meeting on cancer hazard identification, the Joint FAO/WHO Expert Committee on Food Additives (JECFA) conducted a risk assessment exercise, including a review of the acceptable daily intake of aspartame. A summary of these results has been published. Aspartame: it is the risk that matters, not the hazardThe latest set of assessments of potential carcinogenic hazards to humans, published in summary by the International Agency for Research on Cancer (IARC), covers three different agents: aspartame, isoeugenol, and methyleugenol. Most interest will concentrate on just one of these agents, aspartame, an artificial sweetener. IARC has classified aspartame for the first time, as a Group 2B agent, which is “Possibly carcinogenic to humans”. Full-Text PDF" @default.
• W4384156863 created "2023-07-14" @default.
• W4384156863 creator A5000619450 @default.
• W4384156863 creator A5002822533 @default.
• W4384156863 creator A5003874258 @default.
• W4384156863 creator A5008950775 @default.
• W4384156863 creator A5009172923 @default.
• W4384156863 creator A5011558695 @default.
• W4384156863 creator A5013643043 @default.
• W4384156863 creator A5016559128 @default.
• W4384156863 creator A5017217753 @default.
• W4384156863 creator A5018699045 @default.
• W4384156863 creator A5019607152 @default.
• W4384156863 creator A5019952224 @default.
• W4384156863 creator A5020936902 @default.
• W4384156863 creator A5021492691 @default.
• W4384156863 creator A5024536939 @default.
• W4384156863 creator A5024767999 @default.
• W4384156863 creator A5027330034 @default.
• W4384156863 creator A5032065827 @default.
• W4384156863 creator A5033198200 @default.
• W4384156863 creator A5034188143 @default.
• W4384156863 creator A5046109273 @default.
• W4384156863 creator A5049909917 @default.
• W4384156863 creator A5053534566 @default.
• W4384156863 creator A5054289592 @default.
• W4384156863 creator A5065891648 @default.
• W4384156863 creator A5067102861 @default.
• W4384156863 creator A5067228080 @default.
• W4384156863 creator A5067775378 @default.
• W4384156863 creator A5072120321 @default.
• W4384156863 creator A5075100067 @default.
• W4384156863 creator A5075303869 @default.
• W4384156863 creator A5077946706 @default.
• W4384156863 creator A5078787117 @default.
• W4384156863 creator A5079591035 @default.
• W4384156863 creator A5079881408 @default.
• W4384156863 creator A5080307172 @default.
• W4384156863 creator A5086356815 @default.
• W4384156863 creator A5087079627 @default.
• W4384156863 creator A5087655712 @default.
• W4384156863 creator A5088043959 @default.
• W4384156863 creator A5088692725 @default.
• W4384156863 creator A5089024286 @default.
• W4384156863 creator A5090412711 @default.
• W4384156863 creator A5091203715 @default.
• W4384156863 creator A5092460347 @default.
• W4384156863 date "2023-08-01" @default.
• W4384156863 modified "2023-10-17" @default.
• W4384156863 title "Carcinogenicity of aspartame, methyleugenol, and isoeugenol" @default.
• W4384156863 cites W1996445220 @default.
• W4384156863 cites W2016092552 @default.
• W4384156863 cites W2027808454 @default.
• W4384156863 cites W2123880692 @default.
• W4384156863 cites W4220938135 @default.
• W4384156863 cites W4283119820 @default.
• W4384156863 cites W4295903170 @default.
• W4384156863 cites W4381435013 @default.
• W4384156863 doi "https://doi.org/10.1016/s1470-2045(23)00341-8" @default.
• W4384156863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37454664" @default.
• W4384156863 hasPublicationYear "2023" @default.
• W4384156863 type Work @default.
• W4384156863 citedByCount "5" @default.
• W4384156863 countsByYear W43841568632023 @default.
• W4384156863 crossrefType "journal-article" @default.
• W4384156863 hasAuthorship W4384156863A5000619450 @default.
• W4384156863 hasAuthorship W4384156863A5002822533 @default.
• W4384156863 hasAuthorship W4384156863A5003874258 @default.
• W4384156863 hasAuthorship W4384156863A5008950775 @default.
• W4384156863 hasAuthorship W4384156863A5009172923 @default.
• W4384156863 hasAuthorship W4384156863A5011558695 @default.
• W4384156863 hasAuthorship W4384156863A5013643043 @default.
• W4384156863 hasAuthorship W4384156863A5016559128 @default.
• W4384156863 hasAuthorship W4384156863A5017217753 @default.
• W4384156863 hasAuthorship W4384156863A5018699045 @default.
• W4384156863 hasAuthorship W4384156863A5019607152 @default.
• W4384156863 hasAuthorship W4384156863A5019952224 @default.
• W4384156863 hasAuthorship W4384156863A5020936902 @default.
• W4384156863 hasAuthorship W4384156863A5021492691 @default.
• W4384156863 hasAuthorship W4384156863A5024536939 @default.
• W4384156863 hasAuthorship W4384156863A5024767999 @default.
• W4384156863 hasAuthorship W4384156863A5027330034 @default.
• W4384156863 hasAuthorship W4384156863A5032065827 @default.
• W4384156863 hasAuthorship W4384156863A5033198200 @default.
• W4384156863 hasAuthorship W4384156863A5034188143 @default.
• W4384156863 hasAuthorship W4384156863A5046109273 @default.
• W4384156863 hasAuthorship W4384156863A5049909917 @default.
• W4384156863 hasAuthorship W4384156863A5053534566 @default.
• W4384156863 hasAuthorship W4384156863A5054289592 @default.
• W4384156863 hasAuthorship W4384156863A5065891648 @default.
• W4384156863 hasAuthorship W4384156863A5067102861 @default.
• W4384156863 hasAuthorship W4384156863A5067228080 @default.
• W4384156863 hasAuthorship W4384156863A5067775378 @default.
• W4384156863 hasAuthorship W4384156863A5072120321 @default.
• W4384156863 hasAuthorship W4384156863A5075100067 @default.
• W4384156863 hasAuthorship W4384156863A5075303869 @default.
• W4384156863 hasAuthorship W4384156863A5077946706 @default.
• W4384156863 hasAuthorship W4384156863A5078787117 @default.

• next